Disposition of 10000 shares by John Cipriano of CEL SCI at 12.729 subject to Rule 16b-3

Read at macroaxis.com

Published over six months ago View all stories for CEL SCI | CEL SCI Hype Analysis

Disposition of 10000 common stock at 12.729 of CEL SCI by John Cipriano on 11th of April 2024. This event was filed by CEL SCI Corp with SEC on 2020-11-13. Statement of changes in beneficial ownership - SEC Form 4. John Cipriano currently serves as senior vice president - regulatory affairs of CEL SCI Corp

Cash Flow Correlation

CEL SCI's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the CEL SCI's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.

We analyze CEL SCI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CEL SCI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CEL SCI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CEL SCI stock to make a market-neutral strategy. Peer analysis of CEL SCI could also be used in its relative valuation, which is a method of valuing CEL SCI by comparing valuation metrics with similar companies.

Check out CEL SCI Hype Analysis, CEL SCI Correlation and CEL SCI Performance. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.